News for Healthier Living
Clinical Adoption of Histotripsy: A Medical Record Review of Short-Term Outcomes
Histotripsy was cleared by the US FDA for the treatment of primary and metastatic liver tumors almost three years ago.
Researchers sought to gather an early national snapshot of its use for this indication.
August 28, 2026
August 30 2026August 29 2026August 28 2026August 27 2026August 26 2026August 25 2026August 24 2026August 21 2026August 20 2026August 19 2026August 18 2026August 17 2026August 16 2026
|
|
|
|
|